Immunologic and clinical stages in HIV-1-infected Ugandan adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 22, Issue 5, 1999, Pages 509-516

  French, N ^a,b,c   Mujugira, A ^a   Nakiyingi, J ^b   Mulder, D ^a   Janoff, E N ^c   Gilks, C F ^b  

^a Med Res Cncl/Dept Intl D   (Uganda)

^b UNIVERSITY OF MINNESOTA   (United States)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Africa; AIDS; Cause of death; CD4+ T cell counts; HIV; Survival

Indexed keywords

ACCURACY; ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STAGING; SURVIVAL RATE; UGANDA; VALIDATION PROCESS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033572514     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199912150-00013     Document Type: Article

References (27)

1. World Health Organization. UNAIDS Report on the Global HIV/ AIDS Epidemic. Geneva: WHO, 1998.
2. Gilks CF. The clinical challenge of the HIV epidemic in the developing world. Lancet 1993;342:1037-9.
3. Grant AD, Djomand G, De Cock KM. Natural history and spectrum of disease in adults with HIV/AIDS in Africa. AIDS 1997;11(Suppl B): S43-54.
4. Gilks CF, Katabira E, de Cock KM. The challenge of providing effective care for HIV/AIDS in Africa. AIDS 1997;11(Suppl B): 99-106.
5. Morgan D, Maude GH, Malamba SS, et al. HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 1997;350:245-50.
6. Lifson AR, Allen S, Wolf W, et al. Classification of HIV infection and disease in women from Rwanda. Evaluation of the World Health Organization HIV staging system and recommended modifications. Ann Intern Med 1995;122:262-70.
7. Lindan CP, Allen S, Serufilira A, et al. Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med 1992;116:320-8.
8. Anzala OA, Nagelkerke NJ, Bwayo JJ, et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995;171:686-9.
9. Proposed World Health Organization staging system for HIV infection and disease: preliminary testing by an international collaborative cross-sectional study. The WHO International Collaborating Group for the Study of the WHO Staging System. AIDS 1993;7:711-18.
10. Gilks CF, Ojoo SA, Ojoo SC, et al. Invasive pneumococcal disease in a cohort of predominantly HIV-1-infected female sex-workers in Nairobi, Kenya. Lancet 1996;347:718-23.
11. French N, Gilks CF, Mujugira A, Fasching C, O'Brien J, Janoff EN. Pneumococcal vaccination in HIV-1-infected adults in Uganda: humoral response and two vaccine failures. AIDS 1998; 12:1683-9.
12. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:1-19.
13. Morgan D, Ross A, Mayanja B, Malamba S, Whitworth J. Early manifestations (pre-AIDS) of HIV-1 infection in Uganda. AIDS 1998;12:591-6.
14. Okongo M, Morgan D, Mayanja B, Malamba S, Babuwe J, Whitworth J. Causes of death in a rural, population-based HIV-1 natural history cohort in Uganda. Int J Epidemiol 1998;27:698-702.
15. Grant AD, Djomand G, Smets P, et al. Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Cote d'Ivoire. AIDS 1997;11: 1357-64.
16. Gilks CF, Otieno LS, Brindle RJ, et al. The presentation and outcome of HIV-related disease in Nairobi. Q J Med 1992;82:25-32.
17. Taelman H, Clerinx J, Kagame A, Batungwanayo J, Nyirabareja A, Bogaerts J. Cryptococcosis, another growing burden for central Africa. Lancet 1991;338:761.
18. Rothenberg R, Woelfel M, Stoneburner R, Milberg J, Parker R, Truman B. Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med 1987;317:1297-1302.
19. Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease . N Engl J Med 1995;333:751-6.
20. Montaner JS, Le TN, Le N, Craib KJ, Schechter MT. Application of the World Health Organization system for HIV infection in a cohort of homosexual men in developing a prognostically meaningful staging system. AIDS 1992;6:719-24.
21. Hessol NA, Koblin BA, van-Griensven GJ, et al. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. Am J Epidemiol 1994;139:1077-87.
22. Enger C, Graham N, Peng Y, et al. Survival from early, intermediate, and late stages of HIV infection. JAMA 1996;275:1329-34.
23. Sha BE, Benson CA, Pottage JCJ, Urbanski PA, Daugherty SR, Kessler HA. HIV infection in women: an observational study of clinical characteristics, disease progression, and survival for a cohort of women in Chicago. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:486-95.
24. Osmond D, Charlebois E, Lang W, Shiboski S, Moss A. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA 1994;271:1083-7.
25. Mills GD, Jones PD. Relationship between CD4 lymphocyte count and AIDS mortality, 1986-1991. AIDS 1993;7:1383-6.
26. Del amo J, Petruckevitch A, Phillips A, et al. Disease progression and survival in HIV-1-infected Africans in London. AIDS 1998;12: 1203-10.
27. Van Praag E, Fernyak S, Katz AM. The implications of antiretroviral treatments. Geneva: WHO/ASD, 1997.